Concepedia

Andreas O. Schaffland

AO

8

Publications

379

Citations

8

H-Index

1998

Active since

Affiliations

University Hospital of Lausanne(Current)

University Hospital of Geneva

University of Lausanne

Paul Scherrer Institute

Andreas O. Schaffland is an author at University Hospital of Lausanne specializing in oncology, medicine, and cancer research.

Top concepts

Publications per year

1998–2006

8

Publications

8

Organometallic 99mTc-aquaion labels peptide to an unprecedented high specific activity.

André Egli, Roger Alberto, Lesley Tannahill et al. · PubMed · 1999 · 143 citations

Radiolabeled neurotensin analog, 99mTc-NT-XI, evaluated in ductal pancreatic adenocarcinoma patients.

Franz Buchegger, Florent Bonvin, Marek Kosinski et al. · PubMed · 2003 · 98 citations

188Re- and 99mTc-MAG3 as prosthetic groups for labeling amines and peptides

Stefan Guhlke, Andreas O. Schaffland, Paul O. Zamora et al. · Nuclear Medicine and Biology · 1998 · 65 citations

, , +7

131I-rituximab: relationship between immunoreactivity and specific activity.

Andreas O. Schaffland, Franz Buchegger, Marek Kosinski et al. · PubMed · 2004 · 23 citations

Highly efficient DNA incorporation of intratumourally injected [<sup>125</sup>I]iododeoxyuridine under thymidine synthesis blocking in human glioblastoma xenografts

Franz Buchegger, Florence Adamer, Andreas O. Schaffland et al. · International Journal of Cancer · 2004 · 18 citations · Full text

Rows per page

1–5 of 8